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Protein phosphatase-1 (PP1) is a major Ser/Thr
phosphatase that is involved in numerous cellular
processes. PP1-disrupting peptides (PDPs) are
selective chemical tools used to study PP1. They
generate catalytically active PP1 inside cells but do
not bind to the closely related PP2A. Here, we show
that PDPs also do not act directly on PP2B, thus
demonstrating the selectivity of PDPs toward PP1.
We present PDPs with different properties, enabling
reversible versus permanent activation of PP1. We
also show that Ca2+ spiking is an acute effect caused
by PDP-induced activation of PP1. The Ca2+ is
released from internal stores. Our data show that
PDPs can be used as selective chemical genetics
tools to study acute and long-term effects of PP1
activation in intact cells, and PDPs will therefore be
valuable tools to study PP1 biology.
INTRODUCTION
Reversible Ser/Thr phosphorylation of proteins is crucial for
maintaining signal transduction networks in cells, where the
forward (phosphorylation) and the reverse (dephosphorylation)
reactions are mediated by kinases and phosphatases, respec-
tively (Barford et al., 1998). Tight regulation of Ser/Thr phospha-
tase (PSTP) activity and substrate specificity is often accom-
plished by the formation of a diverse set of holoenzymes of
distinct regulatory subunits with a common catalytic subunit
(Bollen, 2001). Protein phosphatase-1 (PP1) is a major PSTP
that belongs to the phosphoprotein phosphatase (PPP) super-
family (Li et al., 2013). It forms a multitude of holoenzymes with
structurally and functionally different regulatory proteins (Hen-
drickx et al., 2009). PP1 is intricately involved in a plethora of
signaling events inside cells, ranging from mitosis (Wu et al.,
2009) and Ca2+ signaling (Aoyama et al., 2011) to apoptosis
(Wang et al., 2001), and thus represents an attractive target for
chemical perturbation to gain insights into the affected cellular
processes. However, selective targeting of PP1 has been a diffi-
cult task due to the similarity of the catalytic site with the other
members of the PPP superfamily, including PP2A and PP2B (cal-Chemistry & Biology 20, 1179–118cineurin, PP3; Cho and Xu, 2007). To this end, we recently devel-
opedmodulators of PP1, PP1-disrupting peptides (PDPs), which
compete with regulatory subunits for binding to PP1 and
generate free PDP-bound PP1 that is catalytically active. We
demonstrated PP1 activity by monitoring the dephosphorylation
of established mitotic substrates of PP1 within hours. PDPs bind
to the RVxF-type docking site on PP1, which is a primary interac-
tion site of most PP1 interactors (Hendrickx et al., 2009), and
PDPs do not bind to PP2A (Chatterjee et al., 2012).
Here, we sought to further evaluate the scope of the PDP
probes.We demonstrate that PDPs also do not act on the closely
related PP2B. Furthermore, we present PDPs with different
properties: one enables a reversible PP1 activation whereas
the other leads to a permanent activation of PP1. In addition,
we show that PDPs can also be used to study acute effects of
PP1. To this end, we chose to investigate if treatment of cells
with PDPs would acutely induce a Ca2+ signal response due to
previous reports showing that PP1 inhibition by okadaic acid
(OA) reduced Ca2+ levels (Kuehnen et al., 2011) and suggesting
PP1 as key player in the regulation of inositol 1,4,5-trisphosphate
receptor (IP3R)-dependent Ca
2+ signaling (Devogelaere et al.,
2007). We show that PDP-induced activation of PP1, but not
PP2A or PP2B activity, causes Ca2+ oscillations originating
from the endoplasmic reticulum (ER) and involving the IP3R,
which acts as a Ca2+ channel that releases ER-stored Ca2+
into the cytoplasm (Bezprozvanny, 2005). Our results demon-
strate the high selectivity of PDPs toward PP1 and show that
PDPs can be used as flexible chemical genetic tools to study
functions of PP1 in intact cells.
RESULTS
PDPs Trigger Intracellular Calcium Release in a
Permanent or Reversible Manner
To assess the effect of PDPs on the induction of Ca2+ release, we
utilized nonexcitable live HeLa cells as our model system and
initially used two cell-permeable PP1 activator peptides, PDP2
and PDP3 (Table 1). Of note, PDP2 is the more potent activator
but is degraded inside cells due to its chemical composition con-
sisting of only naturally occurring amino acids. On the contrary,
PDP3 contains the unnatural amino acid Bpa (L-4-Benzoylphe-
nylalanine) located C-terminally to the RVTF-type docking motif,
which makes it exceptionally stable inside cells but reduces its
activating potency approximately 3-fold (Chatterjee et al.,6, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1179
Table 1. Sequence and Efficacy of the Peptides in Disrupting the
PP1:Inhibitor 2 Complex and Activating PP1
Peptide Sequence Efficacy (EC50; nM)
PDP1 RPKRKRKNARVTFAEAAEII 21 ± 2
PDP2 RRKRPKRKRKNARVTFAEAAEII 53 ± 8
PDP2m RRKRPKRKRKNARATAAEAAEII inactive
PDP3 RRKRPKRKRKNARVTFBpaEAAEII 176 ± 13
From Chatterjee et al., 2012.
EC50, half-maximal effective concentration.
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PP1 Activation Induces Ca2+ Release2012; Table 1). The addition of either of these peptides to inter-
phase HeLa cells induced rapid Ca2+ oscillations, as detected
by ratiometric Ca2+ imaging using Fura-2 (Figures 1A–1C), and
the oscillation frequency increased with higher concentrations
of the peptides (Figures 1A and 1B; Figure S1 available online),
indicating a dose-dependent effect. Other cell types showed
similar responses (Figure S2). The induction of Ca2+ after the
addition of PDP2 was somewhat unexpected because this
PDP variant failed to induce the dephosphorylation of mitotic
substrates of PP1 within hours while PDP3 induced it. This
was explained by the lower stability of PDP2 as compared to
that of PDP3 (Chatterjee et al., 2012). However, Ca2+ oscillations
are observable within seconds, which explains why PDP2 is
active in this setting. Nevertheless, the Ca2+ oscillations induced
by PDP2 displayed a lower frequency in comparison to the ones
evoked by PDP3 (Figures 1A and 1C). A cell-permeable PDP2
analog (PDP2m) with a mutated PP1-docking motif abrogating
its ability to bind to PP1 (Table 1) failed to induce any detectable
Ca2+ oscillations (Figure 1D). This suggests that the Ca2+ oscilla-
tions induced by PDP2 are not due to damage of the plasma
membrane caused by the highly basic cell-penetrating stretch
present at the N terminus ofPDP2, but are related to interference
with PP1 activity.
To distinguish the cellular efficacy of PDP2 and PDP3 in
inducing Ca2+ release, we performed washout experiments
with PDP2 and PDP3 and imaged Ca2+ (Figures 1C and 1E).
We observed that Ca2+ oscillations were completely abolished
after washing off PDP2. On the contrary, the washout of PDP3
had a negligible effect on the overall Ca2+ release, showing sus-
tained elevated Ca2+ oscillations in the cell. This further validates
the proteolytic stability of PDP3 in the cellular environment and
demonstrates the reversibility of PDP2-induced Ca2+ oscilla-
tions. Furthermore, these results suggest that the triggered
Ca2+ oscillations depend on the catalytic activity of PP1.
To further demonstrate that the PDP-induced Ca2+ oscillations
depend on its intracellular uptake and are not due to nonspecific
binding on the cell surface, we used a non-cell-permeable acti-
vator of PP1, PDP1 (Table 1; Chatterjee et al., 2012). PDP1 failed
to induce any significant detectable Ca2+ oscillations (Figure 1F)
despite being 8-fold more efficacious in activating PP1 as deter-
mined in the in vitro dephosphorylation assay (Table 1), thus
demonstrating that the active peptides act inside of the cells.
The PDP-Induced Calcium Release Originates from
Internal Stores and Involves IP3Rs
Next, we aimed to explore the mechanism of PDP-induced Ca2+
spiking. To this end, we used PDP2 rather than PDP3 to prevent1180 Chemistry & Biology 20, 1179–1186, September 19, 2013 ª201effects that could lead to the induction of apoptosis triggered by
sustained Ca2+ elevation (Mattson and Chan, 2003). We first
aimed to identify the source of Ca2+ triggered by the internaliza-
tion of PDP2. Cells were imaged in a Ca2+-free medium in the
presence of ethylene glycol tetraacetic acid (EGTA; Figure 2A)
to chelate extracellular Ca2+. PDP2 still triggered Ca2+ oscilla-
tions under these conditions, albeit with 26% reduction in the
initial amplitude, suggesting that intracellular stores (ER) are
the initial source for the Ca2+ oscillations. For direct measure-
ments of changes in the Ca2+ content of the ER, we applied
the genetically encoded FRET probe D1ER, which consists of
calmodulin fused to a calmodulin-binding peptide (M13) sand-
wiched between enhanced cyan fluorescent protein (ECFP)
and citrine equipped with an ER localization peptide (Palmer
et al., 2004). When a decrease in the Ca2+ concentration in the
ER occurs, calmodulin releases its target peptide M13, resulting
in a decrease of FRET. Upon treatment with PDP2 (Figure 2B),
we observed a decrease in FRET, suggesting that the ER Ca2+
is released and initiates the PDP2-induced Ca2+ transients. As
expected, the control peptide PDP2m did not show any effect.
To further validate the ER as the origin of the initially released
Ca2+, we assessed the involvement of the IP3R. As expected,
PDP2-inducedCa2+ oscillations were completely abolished after
preincubation of the cells with the membrane-permeable IP3R
blockers caffeine (Ehrlich et al., 1994; Figure 2C) or Xestospon-
gin C (Gafni et al., 1997; Figure 2D), suggesting the involvement
of the IP3R in the effect triggered by PDP2. Alternatively, ryano-
dine receptors (RyRs) could trigger the Ca2+ release from the ER
(Lanner et al., 2010). To test whether the RyRs were involved, we
applied 10 mM caffeine on the cells while we monitored Ca2+
levels. Whereas caffeine blocks IP3Rs (Ehrlich et al., 1994), it is
an agonist for RyRs (Lanner et al., 2010). In the case of functional
RyRs one would therefore observe Ca2+ release from the ER,
which we did not (data not shown). Thus, the RyRs are not
involved in the Ca2+ response triggered by PDP2 in the HeLa
cells used here.
To investigate if substrates of major Ser/Thr kinases known to
play a role in Ca2+ signaling are involved, we tested if inhibition of
phosphorylation (mimicking activation of dephosphorylation) of
these substrates would also lead to Ca2+ spiking. The inhibition
of different serine threonine kinase families such as protein
kinase A (PKA), calmodulin-dependent kinase, and protein
kinase C (PKC) using common commercially available inhibitors
did not induce Ca2+ spiking even after longer incubation times
(up 1 hr) and concentrations of the inhibitor to even 100 3 half-
maximal inhibitory concentration (IC50; data not shown). Thus,
either multiple dephosphorylation events are required or the
inhibition of these kinases is not a strong enough signal to trigger
Ca2+ oscillations.
The PDP-InducedCalciumReleaseDepends onPP1, but
not PP2A or PP2B Catalytic Activity
To delineate the contribution of phosphatase activity to the Ca2+
oscillations, we made use of the cell permeable toxins calyculin
A (Cal-A) and OA, which both inhibit PP1 and PP2A (like) phos-
phatases, albeit with different sensitivities (Favre et al., 1997;
Martin et al., 2008; Xu et al., 2003). Whereas Cal-A inhibits PP1
and PP2A with similar efficacy (in vitro, PP1 IC50 = 2 nM and
PP2A IC50 = 1 nM), OA is a more potent inhibitor of PP2A3 Elsevier Ltd All rights reserved
Figure 1. Induction of Ca2+ Transients in HeLa Cells with PP1-Disrupting Peptides Measured by Ratiometric Fura-2 Imaging
Representative traces of ten responding cells are plotted, demonstrating the heterogeneity of the responses. The black bar above the traces indicates the
addition of the peptide.
(A) 20 mM PDP2 (total n = 182 cells; 68% responder).
(B) 50 mM PDP2 (total n = 198 cells; 96% responder).
(C) 20 mM PDP3 with subsequent thorough wash (total n = 123 cells; 98% of the responding cells showed elevated Ca2+ levels after wash).
(D) 50 mM PDP2m (total n = 176 cells, 2% responder).
(E) 20 mM PDP2 with subsequent thorough wash (total n = 97 cells; 3% of the responding cells showed elevated Ca2+ levels after wash).
(F) 20 mM PDP1 (total n = 143 cells, 5% responder).
See also Figures S1 and S2.
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PP1 Activation Induces Ca2+ Release(in vitro, PP2A IC50 = 0.1 nM and PP1 IC50 = 15 nM; Martin et al.,
2008; Chung et al., 2009). In cellular experiments, the amounts of
Cal-A required to inhibit PP1 and PP2A vary depending for
example on incubation time and read-out (Favre et al., 1997;
Martin et al., 2008; Xu et al., 2003). Nevertheless, it is established
that similar concentrations of Cal-A in the low nanomolar rangeChemistry & Biology 20, 1179–118are required for the inhibition of each phosphatase, and lower
concentrations of OA (also in the low nanomolar range) are
required for the inhibition of PP2A than for PP1. These properties
can be used as a means to gather information on which phos-
phatase is likely involved in the process (Martin et al., 2008; Xu
et al., 2003).6, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1181
Figure 2. Origin of the Ca2+
(A) Incubation of HeLa cells in imaging buffer containing no Ca2+ and 250 mM EGTA (n = 98).
(B) Direct measurement of changes in ERCa2+ content with D1ER, a genetically encoded FRET probe (Palmer et al., 2004) (median response of n = 29). To obtain a
homogenous response of the sensor, it was necessary to induce Ca2+ release from the ER with 50 mM PDP2. Data are represented as median ± average quartile
distance.
(C) Preincubation with 10 mM caffeine (n = 87, no responder).
(D) 2 mM xestospongin C (n = 96; no responder) for 10 min prior to the measurement.
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increasing concentrations of Cal-A added to the cells, we noted
a clear decrease in the frequency and amplitude of the Ca2+
oscillations that was not concentration-dependent starting
from 10 nMCal-A (Figure 3A). These data indicate that phospha-
tase catalytic activity is required to induce the Ca2+ oscillations.
OA showed a concentration-dependent dampening effect start-
ing at a concentration of 20 nM, and no significant effect with
lower concentrations (Figure 3A). This result suggests that
PP1, not PP2A, is the major phosphatase mediating the Ca2+
oscillations (Martin et al., 2008; Xu et al., 2003). This is also in
agreement with our previous report, where we showed selec-
tivity of PDPs toward PP1 over PP2A (Chatterjee et al., 2012).
We further sought to demonstrate that PDP2 indeed elevated
the activity of PP1 under the imaging conditions. Enhanced cat-
alytic activity of PP1 was determined in living cells using the
FRET-based kinase activity reporter, KCP-1. Pleckstrin, which
is a specific substrate for PKCs and is sandwiched between
green fluorescent protein and yellow fluorescent protein (YFP)
in KCP-1 (Schleifenbaum et al., 2004), undergoes a conforma-
tional change upon phosphorylation by PKC, resulting in an in-
crease of FRET. Accordingly, dephosphorylation should lead to
a decrease in FRET. Indeed, we observed that KCP-1, after
phosphorylation by PKC induced by phorbol 12-myristate 13-1182 Chemistry & Biology 20, 1179–1186, September 19, 2013 ª201acetate (PMA), underwent rapid dephosphorylation with the
addition of PDP2, counteracting the enhanced PKC activity (Fig-
ure 3B). Addition of PDP2m under the same conditions did not
show any change of the FRET signal (Figure 3B).
PP2B is closely related to PP1 (Li et al., 2013). As opposed to
PP1, however, PP2B requires Ca2+ to be active (Shibasaki et al.,
2002). The rapid dephosphorylation of KCP-1 was also observed
when the intracellular Ca2+ was chelated by the addition of 1,2-
bis(O-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid tetra
(acetoxymethyl) ester (BAPTA-AM) (Figure 3B). This observation
suggests that PP2B is not involved in the dephosphorylation
event because intracellular Ca2+ is required for PP2B activity
(Shibasaki et al., 2002). Together, these results demonstrate
that PDP2 highly selectively activates PP1 inside living cells
and does not directly activate PP2A and PP2B. In addition,
together with the previously described reversibility of the action
of PDP2, these results confirm that the triggered Ca2+ oscilla-
tions are caused by catalytically active PP1.
PDPs Do Not Act Directly on PP2B
PP1 and PP2B display a considerably conserved hydrophobic
channel on the surface opposite to the catalytic site (Roy and
Cyert, 2009). The co-crystal structure of PDP2 in complex with
PP1 revealed that PDP2 binds to this hydrophobic site, the3 Elsevier Ltd All rights reserved
Figure 3. Ca2+ Spiking Is Triggered by PDP2-Induced PP1 Activation
in HeLa Cells
(A) Median primary amplitudes of Ca2+ responses after incubation with
different concentrations of the protein phosphatase inhibitors Cal-A (green
bars) andOA (red bars) for 10min and subsequent treatment with 20 mMPDP2.
The control cells were not treated with inhibitors (blue bar). Significant
reduction of Ca2+ amplitude by pretreatment with 5 nM Cal-A: p < 0.02 and
20 nM OA: p < 0.05.
(B) Response of the genetically encoded kinase reporter, specific for PKCs,
upon peptide treatment after activation with 0.5 mM PMA. PDP2 (blue graph,
total n = 52; p < 0.05); PDP2m (green graph, total n = 36); and PDP2 + BAPTA-
AM (intracellular chelator of Ca2+; red graph, total n = 42). Data are represented
as median ± average quartile distance.
Figure 4. PDP2 Does Not Act on PP2B
(A) Response of the PP2B-specific FRET reporter CaNAR1 upon 20 mM pep-
tide treatment (PDP2: total n = 42, PDP2m: total n = 24, and PDP2 + BAPTA:
total n = 36).
(B) Pretreatment for 2 hr with 40 nM of the PP2B inhibitor FK506 (n = 117 cells)
reduced the primary amplitude slightly (p % 5) after treatment with 20 mM
PDP2 compared to nontreated cells (control, n = 119 cells). Data are repre-
sented as median ± average quartile distance.
See also Figures S3 and S4.
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PP1 Activation Induces Ca2+ ReleaseRVxF-binding site, on PP1 (Chatterjee et al., 2012), and peptides
possessing the sequence PxIxIT have been shown to bind this
hydrophobic substrate docking site on PP2B (Li et al., 2007).
Although the peptide sequences recognizing this channel on
each phosphatase are not the same, both sequences have a
strongly hydrophobic character and this could lead to nonspe-
cific binding of PDP2 to PP2B. Thus, to exclude that PP2B activ-
ity is in any way affected by PDP2, we used the FRET-based
PP2B phosphatase activity sensor CaNAR1 (Newman and
Zhang, 2008). CaNAR1 uses a PP2B activity-dependent molec-
ular switch based on the N-terminal regulatory domain of the
nuclear factor of activated T cells as a specific substrate, sand-
wiched between CFP and YFP. This PP2B activity sensor con-Chemistry & Biology 20, 1179–118tains the PxIxIT docking motif. Activation of PP2B is measured
by an increase in FRET (Newman and Zhang, 2008). We
observed that the addition of PDP2 resulted in activation of
PP2B (Figure 4A). However, when the intracellular Ca2+ was
chelated using BAPTA-AM, there was no evident activation of
PP2B by PDP2 (Figure 4A). These results demonstrate that
PP2B activity is not impaired by PDP2, because PP2B is still
active after the addition of PDP2 in the presence of Ca2+ ions.
This shows that PDP2 cannot outcompete the substrate of the
hydrophobic binding pocket on PP2B under these conditions,
thus having either no or insufficient affinity to this pocket.
Furthermore, we tested if inhibition of PP2Bwould have an effect
on Ca2+ spiking triggered by PDP2. Preincubation with 40 nM
FK506, a potent small molecule inhibitor of PP2B (Martin et al.,
2008), resulted in a significant decrease of PP2B activity
measured using CaNAR1 (see Figure S3). Conversely, treatment
with 20 mM PDP2 after preincubation with FK506 only resulted in
a slight decrease in the primary Ca2+ amplitude (Figure 4B) and
did not lead to a decrease of the longer term spiking compared
to cells that were not treated with FK506 (Figure S4). Together
with the reversibility of the Ca2+ response shown earlier (Fig-
ure 1C and 1E), these results confirm that PP2B plays a minor
or no role in the Ca2+ response triggered by PDP2. These results
indicate that PP2B is not directly affected by PDP2. Thus, PDP2
selectively activates PP1 and induces the release of Ca2+, which
subsequently leads to the further downstream activation of
PP2B.
DISCUSSION
We demonstrate that PDPs are selective toward PP1 over PP2A
and PP2B. Furthermore, PDP2 induces PP1 activation in live
cells in a reversible manner. Therefore, PDP2 may serve as a6, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1183
Figure 5. Potential Mechanism of Ca2+
Transients Induced by Chemical PP1 Acti-
vation
The catalytic subunits of PP1 are bound to
different subunits regulating PP1 activity. Adding
the cell-permeable peptide PDP2 outcompetes
some inhibitory subunits, resulting in an increase
of PP1 activity. Our data (Figure 2) suggest that the
initial Ca2+ increase depends on Ca2+ release from
the internal pools mediated by the IP3 receptor.
Inhibition of PP1 activity leads to a reduction of the
Ca2+ response.
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PP1 Activation Induces Ca2+ Releasepowerful tool to acutely perturb signaling cascades involving
Ser/Thr kinases and PP1. Depending on the process of interest,
this finding enables the application of either the reversibly acting,
less stable PDP2, or alternatively, the more stable PDP3 for
studies in which PP1 activity is selectively triggered, but not
PP2A or PP2B phosphatase activity.
Moreover, we show that chemical PP1 activation by PDPs can
be used to study acute responses of PP1 signaling. Chemical
activation of PP1 induces cellular Ca2+ oscillations (Figure 5),
and PP1 catalytic activity is a sufficient signal for inducing Ca2+
spiking. We eliminated the involvement of two of the major
PSTPs, PP2A and PP2B, in the initial calcium response, which
is important information given the small number of PSTPs that
are able to perform a large number of different dephosphoryla-
tion reactions (Li et al., 2013).
We previously demonstrated that PDPs create pools of active
PP1 that dephosphorylate nearby substrates by displacing the
regulatory proteins in an affinity-dependent manner. Therefore,
not all but many PP1 holoenzymes are disrupted by PDPs. Treat-
ment of cells with PDP3 rescued the dephosphorylation of
histone 3 when the PP1 regulatory protein Repo-Man, which tar-
gets PP1 to this substrate, was knocked down. This demon-
strated that the active PDP:PP1 complex acts on substrates
that would usually require the interaction of a regulatory protein
with the RVxF-binding site on PP1 (Chatterjee et al., 2012). Thus,
the PDP:PP1 complex is able to dephosphorylate PP1’s sub-
strates regardless of the availability of the RVxF-binding site on
PP1. Given that PP1 is estimated to dephosphorylate the major-
ity of protein dephosphorylation events in eukaryotic cells (Bollen
et al., 2010), it is unclear if a dephosphorylation event on only one
substrate of PP1 would be sufficient to trigger the Ca2+
response, or if the interplay of dephosphorylation events of
different substrates is required (Figure 5). The inhibition of Ser/
Thr kinases involved in Ca2+ signaling did not lead to a Ca2+
release, suggesting that multiple rather than only a few specific
PP1 substrates are involved in this process.
In HeLa cells, the initial source of Ca2+ release stimulated by
PP1 activity is intracellular, and the IP3R is involved in the initial
Ca2+ release (Figure 5). Changes in the phosphorylation level
of the IP3R could be one of the mechanisms leading to the
Ca2+ response to chemical PP1 activation (Figure 5), because
IP3R from rat cerebellum was reported to be a macromolecular
complex that includes PKA and PP1 among other proteins
(DeSouza et al., 2002). Reports on the effect of PKA phosphory-
lation of the IP3R with respect to enhanced or reduced Ca
2+
release are contradictory (DeSouza et al., 2002), demonstrating1184 Chemistry & Biology 20, 1179–1186, September 19, 2013 ª201once more the difficulty in studying these mechanisms. Whereas
in vitro, lacking the presence of other proteins, phosphorylation
enhanced Ca2+ release (DeSouza et al., 2002; Tang et al.,
2003), in MCF-7 cells dephosphorylation by PP1—contrary to
the effect of PKA phosphorylation—increased adenosine
triphosphate (ATP) and inositol(1,4,5)phosphate (IP3)-induced
IP3R channel activity (Xu et al., 2007). Our results support the
latter scenario; however, this complex process may be differen-
tially regulated in different cell types (DeSouza et al., 2002).
Nevertheless, it was previously unclear if PP1 activity leads to
up- or downregulation of Ca2+ release, and we demonstrate
that PP1 activity in general leads to upregulation of the Ca2+
response.
The sustained activation of PP1 as the cause of the enhanced
Ca2+ spiking is in agreement with a report on the mechanism of
PP1-mediated regulation of the action of the protein IRBIT.
IRBIT is an IP3R binding protein that competes with IP3 for bind-
ing of the IP3R. IRBIT inhibits the IP3-mediated activation of
IP3R, leading to reduced Ca
2+ release. Dephosphorylation of
IRBIT by PP1 was suggested to lead to an increased sensitiza-
tion of the IP3R to IP3 and thus to a sustained Ca
2+ response
(Devogelaere et al., 2007). Thus, IRBIT could also be a substrate
candidate involved in Ca2+ release triggered by chemical PP1
activation.
Considering the complexity of PP1 biology, the multitude of
PP1 substrates (Bollen et al., 2010; Li et al., 2013), and the fact
that positively charged Ca2+ and negatively charged phosphate
ions are the two primary signaling elements of cells (Clapham,
2007), it will take a great effort to decipher the mechanisms
that connect PP1 to Ca2+ signaling. Our evaluation of the scope
of PDPs demonstrates that PDPs are highly valuable tools to
study PP1 signaling, and therefore promise to become a crucial
part of studies to elucidate such complex biologic mechanisms.
Finally, a recent report describes impaired activity of PP1 and
the subsequent inhibition of insulin secretion from pancreatic b
cells by the action of leptin, leading to the development of type
2 diabetes mellitus (Kuehnen et al., 2011). Chemical inhibition
of PP1 in pancreatic b cells also inhibits insulin secretion and re-
duces Ca2+ levels (Sato et al., 1998), and reduced Ca2+ levels
lead to a decrease in the vesicular fusion and exocytosis of the
insulin granules (Sim et al., 2003). Based on these reports and
our observations, it would be worth exploring whether the
PDP-mediated activation of PP1 could induce Ca2+ release
and increase insulin secretion in pancreatic b cells. This could
lead to the exciting possibility of PP1 activation as a different
therapeutic approach to treat type 2 diabetes mellitus.3 Elsevier Ltd All rights reserved
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Chemical modulators of enzyme activity are valuable tools
to decipher roles and regulation of proteins of interest. In
addition to advancing our understanding of these roles,
chemical tools have been the basis for lead compounds in
the development of therapeutics. Over many decades, PP1
research has remained extraordinarily challenging for a
large part due to the lack of selective chemical modulators
of its phosphatase activity that are active inside living cells.
The evaluation of the scope and selectivity of our PP1-dis-
rupting peptides presented here demonstrates that (1) they
activate PP1 catalytic activity inside living cells, (2) they are
truly selective toward PP1 over PP2A and PP2B, (3) they
can be used for acute and long-term studies on the pertur-
bation of PP1 activity, and (4) they can be used as reversible
or permanent activators of PP1. Thus, PP1-disrupting pep-
tides are valuable tools that will help to elucidate PP1
signaling in health and disease in the future. Furthermore,
we show that chemical PP1 activation leads to Ca2+ oscilla-
tions in different model cell lines. Our findings pave the way
for future studies on PP1 activation to trigger Ca2+-induced
signaling, including the release of insulin. Combined with
our findings that PP1 activation counteracts Aurora B kinase
signaling, this opens up a new chapter of research regarding
the therapeutic potential of PP1 activation.
EXPERIMENTAL PROCEDURES
Peptide Synthesis
Peptideswere synthesized on aMultisyntech peptide synthesizer using a stan-
dard Fmoc solid phase peptide synthesis protocol. Double couplings were
performed with Fmoc-amino acids (5 eq), DIEA (N,N-diisopropylethylamine;
6 eq), HBTU (O-benzotriazole-N,N,N0,N0-tetramethyl-uronium-hexafluoro-
phosphate; 5 eq), and HOBt (N-hydroxybenzotriazole; 5 eq) in 1 ml DMF
(N,N-dimethylformamide) using Rink amide resin. The Fmoc deprotection
was carried out using 20%piperidine. All peptideswere acetylated at the N ter-
minus using 1:9 (vol/vol) acetic anhydride:pyridine. The peptides were cleaved
from resin using cleavage cocktail (95% trifluoroacetic acid: 2.5% triisopropyl-
silane: 2.5% H2O), ether-precipitated, purified with high-performance liquid
chromatography, and analyzed with mass spectroscopy by MALDI.
Cell Culture and Transfection
Cell experiments were performed with HeLa (LGC-ATCC, No. CCL-2), U2OS,
or HEK293 (a kind gift of Peter Lipp) cells. The constructs we used originated
from previous work as follows: KCP-1 from Schleifenbaum et al. (2004),
CaNAR1 from Newman and Zhang (2008), and D1ER from Palmer et al.
(2006). HeLa and U2OS cells were passaged and maintained in DMEM
(GIBCO) supplemented with 10% FBS (GIBCO) and 0.1 mg/ml primocin
(Invitrogen). HEK293 were grown in Dulbecco’s modified Eagle’s medium
with 4.5 g/l glucose (GIBCO), 10% fetal bovine serum, 1 mM sodium pyruvate
(GIBCO), and 0.1 mg/ml primocin. For imaging, cells were seeded in eight-
chambered LabTeks (NUNC) 20–24 hr before imaging and transfected at
approximately 50% confluence with FuGENE HD reagent (Promega). Trans-
fections were performed in Opti-MEM (GIBCO) according to the manufac-
turer’s instructions. Cells were gently washed 20–24 hr after transfection and
incubated in imaging medium (20 mM HEPES, pH 7.4, 115 mM NaCl, 1.8 mM
CaCl2, 1.2 mM MgCl2, 1.2 mM K2HPO4, and 2 g/l D-glucose) at 37
C for at
least 15 min before imaging.
Microscopy
For ratiometric Ca2+ imaging, cells were loadedwith 2 mMFura-2 (Life Technol-
ogies) in Tyrode’s solution for 30 min at room temperature. We carried out the
measurements on an Olympus Cell-R equipped with an Image EM CCD cam-Chemistry & Biology 20, 1179–118era (Hamamatsu) and a MT20 light source (stabilized Xe-lamp) controlled with
the xCELLence software (Olympus) using the 203/0.4 air objective. Excitation
filters, 340/30 and 387/20, together with a 535/50 emission filter were used.
Measurements with ratiometric FRET (CFP/YFP) probes, CaNAR1, D1ER,
and KCP-1 were captured on a Leica AF7000 wide field microscope. A 427/
10 nm excitation filter combined with a 440/520 nm dichroic and emission fil-
ters for CFP (472/30 nm) and YFP (542/27 nm) were used.
All experiments were performed at 37C. The phorbol ester PMA, 1,2-bis(O-
aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid tetra(acetoxymethyl) ester
(BAPTA-AM), IP3R inhibitors Xestospongin C and caffeine, protein phospha-
tase inhibitors OA and Cal-A were supplied by Merck (Darmstadt). We apply
calcium signaling as an indirect read-out of phosphatase activity measured
in single live cells. To determine the incubation time required to observe a
response of inhibitors in this system, in preliminary experiments we added
OA and Cal-A (40 nM each) after induction of Ca2+ transients by PDP2. We
observed a decrease of transients (amplitude and occurrence) after 5–7 min.
Thus, when quantifying the primary transient, we applied the inhibitors
10 min prior to the peptide.
Data Analysis
Stored images were analyzed with using Fiji (Schindelin et al., 2012). Before
measuring changes in brightness, background subtraction was carried out.
To analyze FRET, changes of donor and acceptor channel, for Fura-2 emission
intensities after 340 and 387 excitation, were divided by each other as indi-
cated for each probe, respectively. The change of ratios was measured from
the whole cell area.
Region of interest fluorescence over time data were transferred into Excel
and further processed for data display and analysis. All results of our life cell
imaging with genetically encoded probes were analyzed in cells displaying a
wide range of expression levels (resting fluorescence levels differed by up to
a factor of 10 between cells; data not shown).
Signal was defined as three consecutive time points with values higher/
lower than average ± 3* SD of the baseline. Maximum amplitudes were calcu-
lated by subtracting average baseline from the maximum of the first Ca2+ tran-
sient after peptide was added to the cells. Data from at least three independent
experiments were analyzed. Medians were plotted with quartile distances as a
measure of deviation. To test for differences, we applied the U-test.
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